Cabotegravir and rilpivirine (Intramuscular)

Medically reviewed by Drugs.com. Last updated on Apr 24, 2022.

Available Dosage Forms:

• Suspension, Extended Release

Uses for cabotegravir and rilpivirine

Cabotegravir and rilpivirine combination injection are used together for the treatment of the human immunodeficiency virus type 1 (HIV-1) infection. HIV is the virus that causes acquired immune deficiency syndrome (AIDS). Cabotegravir and rilpivirine is usually given to patients to replace their current anti-HIV medicines when their healthcare provider determines that they meet certain requirements.

Cabotegravir and rilpivirine combination injection will not cure or prevent HIV infection or AIDS. It helps keep HIV from reproducing and appears to slow down the destruction of the immune system. This may help delay problems that are usually related to AIDS or HIV disease from occurring. Cabotegravir and rilpivirine will not keep you from spreading HIV to other people. People who receive cabotegravir and rilpivirine may continue to have other problems usually related to AIDS or HIV disease.

Cabotegravir and rilpivirine is to be given only by or under the direct supervision of your doctor.

Before using cabotegravir and rilpivirine

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For cabotegravir and rilpivirine, the following should be considered:

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to cabotegravir and rilpivirine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

Appropriate studies have not been performed on the relationship of age to the effects of cabotegravir and rilpivirine combination injection in children younger than 12 years of age or weighing less than 35 kilograms (kg). Safety and efficacy have not been established.

Geriatric

Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of cabotegravir and rilpivirine combination injection in the elderly. However, elderly patients are more likely to have age-related kidney, liver, or heart problems, which may require caution or patients receiving cabotegravir and rilpivirine.

Breastfeeding

There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.

Interactions with medicines

Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are receiving cabotegravir and rilpivirine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.

Using cabotegravir and rilpivirine with any of the following medicines is ...